Has Jessica Lowery received payments from drug or device companies?

Yes. Drug and device makers reported $15,746 in general payments to Jessica Lowery across 785 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jessica Lowery did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jessica Lowery come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jessica Lowery

Nurse Practitioner · Scottsdale, AZNPI 1396162715

Payments from drug & device makers

$15,746in general payments, 2019–2025

Across 785 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$2K
AbbVie$1K
SK Life Science, Inc.$973
Mallinckrodt Hospital Products Inc.$894
ANI Pharmaceuticals, Inc.$813
Lundbeck LLC$775
plus $10K from 35 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	103	$1,679
AbbVie	65	$1,099
SK Life Science, Inc.	36	$973
Mallinckrodt Hospital Products Inc.	36	$894
ANI Pharmaceuticals, Inc.	45	$813
Lundbeck LLC	41	$775
Biogen	35	$669
Otsuka America Pharmaceutical, Inc.	37	$642
Novartis	36	$641
Lilly USA, LLC	30	$630
Teva Pharmaceuticals USA, Inc.	35	$624
Genentech USA, Inc.	28	$573
AstraZeneca	28	$559
Amgen(2 entities)	32	$548
TG Therapeutics, Inc.	31	$513
EMD Serono, Inc.	24	$489
Axsome Therapeutics, Inc.	16	$474
Acadia Pharmaceuticals Inc	23	$447
UCB, Inc.	15	$383
Argenx US, Inc.	15	$331
Eisai Inc.	11	$324
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	15	$284
Medtronic	2	$199
Catalyst Pharmaceuticals, Inc.	6	$141
Takeda Pharmaceuticals U.S.A., Inc.	6	$135
Averitas Pharma Inc.	2	$134
Sanofi	4	$116
Neurocrine Biosciences, Inc.	5	$114
E.r. Squibb & Sons, L.L.C.	1	$93
Bristol Myers Squibb	4	$75
Johnson & Johnson(2 entities)	3	$61
Vanda Pharmaceuticals Inc.	2	$54
Upsher-smith Laboratories LLC	2	$47
Acorda Therapeutics, Inc	2	$46
Tonix Medicines, Inc.	2	$40
Merz Pharmaceuticals, LLC	2	$31
Jazz Pharmaceuticals Inc.	1	$29
Idorsia Pharmaceuticals US Inc	1	$21
Biohaven Pharmaceuticals, Inc.	1	$17
Alnylam Pharmaceuticals Inc.	1	$16
Novo Nordisk	1	$14

How this compares

$15,746 in reported general payments places this provider in the 95th percentile of 1,719 nurse practitioner providers in Arizona.

See all nurse practitioner providers in Arizona →

Medicare billing

Part B allowed, 2024

$38,808

Medicare patients

Services billed

3,286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Scottsdale

Kristen HerzogScottsdale$162K
Kelley RoneScottsdale$29K
Jill StudyScottsdale$24K
Jennifer BarbosaScottsdale$21K
Ronald OrdasScottsdale$8K
Theresa LongoScottsdale$8K
Samantha DeberryScottsdale$8K
Meagan GruwellScottsdale$7K
Ann MooreGlendale$2.1M
Andrea KesslerLitchfield Park$780K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →